Skip to main content
SpringerLink
Log in

Dialysis in the Older Adult: Management of CKD–MBD

  • Chapter
  • First Online:
Dialysis in Older Adults

Abstract

CKD–MBD is strongly associated with mortality and morbidity in the general dialysis population. The spectrum of clinical long-term consequences of CKD–MBD includes abnormal mineral metabolism; vascular, valvular, and soft-tissue calcifications; uremic bone disease; bone pain; and, last but not least, bone fractures. A consensus statement on treatment targets and principles for CKD–MBD in CKD and dialysis patients has been issued recently in the form of guidelines by the KDIGO group [1]. However, these guidelines do not specifically address specific treatment modalities in the subpopulation of elderly dialysis patients.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 16.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Kidney Disease Improving Global Outcome (KDIGO) CKD-MBD Work Group (2009) KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease – mineral and bone disorder (CKD-MBD). Kidney Int Suppl 76:S1–S130

    Google Scholar 

  2. Chauveau P, Combe C, Laville M et al (2001) Factors influencing survival in hemodialysis patients aged older than 75 years: 2.5 years outcome study. Am J Kidney Dis 37:997–1003

    Article  CAS  PubMed  Google Scholar 

  3. Cohen LM, Ruthazer R, Moss AH, Germain MJ (2010) Predicting six-month mortality for patients who are on maintenance hemodialysis. Clin J Am Soc Nephrol 5:72–79

    Article  PubMed  PubMed Central  Google Scholar 

  4. Pelletier S, Roth H, Bouchet J-L et al (2010) Mineral and bone disease pattern in elderly hemodialysis patients. Nephrol Dial Transplant 25:3062–3070

    Article  CAS  PubMed  Google Scholar 

  5. Kiss I, Kiss Z, Ambrus C et al (2010) Age-dependent parathormone levels and different CKD-MBD treatment practices of dialysis patients in Hungary – results from a nationwide clinical audit. BMC Nephrol 14:155–162

    Article  Google Scholar 

  6. Alem AM, Sherrard DJ, Gillen DL et al (2000) Increased risk of hip fractures among patients with end-stage renal disease. Kidney Int 58:396–399

    Article  CAS  PubMed  Google Scholar 

  7. Wagner J, Jhaveri KD, Rosen L et al (2014) Increased bone fractures among elderly United States hemodialysis patients. Nephrol Dial Transplant 29:146–151

    Article  PubMed  Google Scholar 

  8. Beaubrun AC, Kilpatrick RD, Freburger JK et al (2013) Temporal trends in fracture rates and post-discharge outcomes among hemodialysis patients. J Am Soc Nephrol 24:1461–1469

    Article  PubMed  PubMed Central  Google Scholar 

  9. Tentori F, McCullough K, Kilpatrick RD et al (2014) High rates of death and hospitalization follow bone fracture among hemodialysis patients. Kidney Int 85:166–173

    Article  PubMed  PubMed Central  Google Scholar 

  10. Berger C, Langsetmo L, Joseph L et al (2008) Change in bone mineral density as a function of age in women and men and association with the use of antiresorptive agents. CMAJ 178:1660–1668

    Article  PubMed  PubMed Central  Google Scholar 

  11. Kansal S, Fried L (2010) Bone disease in elderly individuals with CKD. Adv Chronic Kidney Dis 17:e41–e51

    Article  PubMed  Google Scholar 

  12. Kazama JJ, Iwasaki Y, Fukagawa M (2013) Uremic osteoporosis. Kidney Int Suppl 3:446–450

    Article  CAS  Google Scholar 

  13. Barreto FC, Barrto DV, Moyses RMA et al (2006) Osteoporosis in dialysis patients revisited by bone histomorphometry: a new insight into an old problem. Kidney Int 69:1852–1857

    Article  CAS  PubMed  Google Scholar 

  14. Lewiecki EM, Laster AJ (2006) Clinical applications of vertebral fracture assessment by dual-energy x-ray absorptiometry. J Clin Endo Metab 91:4215–4222

    Article  CAS  Google Scholar 

  15. National Osteoporosis Foundation (2013) Clinician’s guide to prevention and treatment of osteoporosis. National Osteoporosis Foundation, Washington, DC

    Google Scholar 

  16. Johnson DW, McIntyre HD, Brown A et al (1996) The role of DEXA bone densitometry in evaluating renal osteodystrophy in continuous ambulatory peritoneal dialysis patients. Periton Dial Int 16:34–40

    CAS  Google Scholar 

  17. Masud T, Langley S, Wiltshire P et al (1993) Effect of spinal osteophytosis on bone mineral density measurements in vertebral osteoporosis. BMJ 307:172–173

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Muxí Á, Torregrosa J-V, Fuster D et al (2009) Arteriovenous fistula affects bone mineral density measurements in end-stage renal failure patients. Clin J Am Soc Nephrol 4:1494–1499

    Article  PubMed  PubMed Central  Google Scholar 

  19. Letdumrongluk P, Lau WL, Park J et al (2013) Impact of age on survival predictability of bone turnover markers in hemodialysis patients. Nephrol Dial Transplant 28:2535–2545

    Article  Google Scholar 

  20. Singh H (2009) Bone disease and calcium abnormalities in elderly patients with CKD. Am Soc Nephrol Online Curricula: Geriatric Nephrology, https://www.asn-online.org/education/distancelearning/curricula/geriatrics/Chapter14.pdf

  21. McClung MR, Grauer A, Boonen S et al (2014) Romosozumab in postmenopausal women with low bone mineral density. New Engl J Med 370(5):412–420

    Google Scholar 

  22. Jackson RD, LaCroix AZ, Gass M et al (2006) Calcium plus vitamin D supplementation and risk of fractures. N Engl J Med 354:669–683

    Article  CAS  PubMed  Google Scholar 

  23. Toussaint ND, Elder G, Kerr PG (2009) Bisphosphonates in chronic kidney disease; balancing potential benefits and adverse effects on bone and soft tissue. Clin J Am Soc Nephrol 4:221–233

    Article  CAS  PubMed  Google Scholar 

  24. Wetmore JB, Benet LZ, Kleinstuck D, Frasetto L (2005) Effects of short-term alendronate on bone mineral density in hemodialysis patients. Nephrology (Carlton) 10:393–399

    Article  CAS  Google Scholar 

  25. Miller PD (2007) Is there a role for bisphosphonates in chronic kidney disease? Semin Dial 20:186–190

    Article  PubMed  Google Scholar 

  26. Drueke TB (2008) Is parathyroid hormone measurement useful for the diagnosis of renal bone disease? Kidney Int 73:674–676

    Article  CAS  PubMed  Google Scholar 

  27. Hernández E, Valera R, Alonzo E et al (2003) Effects of raloxifene on bone metabolism and serum lipids in postmenopausal women on chronic hemodialysis. Kidney Int 63:2269–2274

    Article  PubMed  Google Scholar 

  28. Jamal SA, Ljunggren O, Stehman-Breen C et al (2011) Effects of denosumab on fracture and bone mineral density by level of kidney function. J Bone Miner Res 26:1829

    Article  CAS  PubMed  Google Scholar 

  29. McCormick BB, Davis J, Burns KD (2012) Severe hypocalcemia following denosumab injection in a hemodialysis patient. Am J Kidney Dis 60:626–628

    Article  PubMed  Google Scholar 

  30. Miller PD, Schwartz EN, Chen P et al (2007) Teriparatide in postmenopausal women with osteoporosis and mild or moderate renal impairment. Osteoporosis Int 18:59–68

    Article  CAS  Google Scholar 

  31. Overman RA, Borse M, Gourlay ML (2013) Salmon calcitonin use and associated cancer risk. Ann Pharmacother 47:1675–1684

    Article  CAS  PubMed  Google Scholar 

  32. Cunningham J, Danese M, Olson K et al (2005) Effects of the calcimimetic cinacalcet HCl on cardiovascular disease, fracture, and health-related quality of life in secondary hyperparathyroidism. Kidney Int 68:1793–1800

    Article  CAS  PubMed  Google Scholar 

  33. Arneson TJ, Li S, Liu J et al (2013) Trends in hip fracture rates in US hemodialysis patients, 1993–2010. Am J Kidney Dis 62:747–754

    Article  PubMed  Google Scholar 

  34. The EVOLVE Trial Investigators (2012) Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis. N Engl J Med 367:2482–2494

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Nephrology, Department of Internal Medicine, Vivantes Klinikum im Friedrichshain, Landsberger Alle 49, Berlin, 10249, Germany

    Martin K. Kuhlmann MD

Authors
  1. Martin K. Kuhlmann MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Martin K. Kuhlmann MD .

Editor information

Editors and Affiliations

  1. University of Missouri Columbia, Div of Nephrology Department of Medicine, Columbia, Missouri, USA

    Madhukar Misra

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer Science+Business Media New York

About this chapter

Cite this chapter

Kuhlmann, M.K. (2016). Dialysis in the Older Adult: Management of CKD–MBD. In: Misra, M. (eds) Dialysis in Older Adults. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-3320-4_10

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-3320-4_10

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-3318-1

  • Online ISBN: 978-1-4939-3320-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation